We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App





AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission

By HospiMedica International staff writers
Posted on 08 Apr 2022
Print article
Image: A new study has set an international benchmark in applying AI for monitoring and managing COVID-19 (Photo courtesy of Unsplash)
Image: A new study has set an international benchmark in applying AI for monitoring and managing COVID-19 (Photo courtesy of Unsplash)

A study by a team of researchers has become an international benchmark for the reliable use of artificial intelligence (AI) in monitoring and managing COVID-19.

In an article published in the Journal of the American Medical Informatics Association, the research team at the Universitat Politècnica de València (UPV, Valencia, Spain) has demonstrated the limitations that the variability or heterogeneity of data may have in reliably applying AI when it comes from multiple sources, e.g. a range of hospitals or countries. The article sets out the key aspects of potential solutions to such limitations. Furthermore, the team has developed new tools based on this study to help describe and classify patients with COVID-19.

The researchers have also developed an AI model for the early prediction of mortality (within the first 30 days of admission to the emergency department), focusing principally on adults aged over 50. They have also developed a deep learning application that helps to predict severity in all age groups, with the advantage of being able to operate even with incomplete patient information, offering robust and reliable AI in the event of data quality issues.

“These predictive models can help to select the best treatment for each patient according to their mortality risk, and to plan and manage resources in cases of low availability of resources, and in a way that can withstand potential uncertainties in the available information,” said Carlos Sáez, a member of the BDSLab-ITACA group research team at Universitat Politècnica de València, who coordinated the study.

In addition, following a study of nearly 800,000 COVID-19 cases, the researchers have developed a new technique to investigate subphenotypes (dividing patient populations into meaningful groups) in line with clinical characteristics. This technique, based on meta-clustering exploratory AI, can be used to automatically obtain a large number of results at different socio-demographic levels (by age group, gender, and combinations thereof), which would otherwise have to be carried out manually, involving additional work. This technique not only encourages non-discrimination, but also presents the results to the user in a detailed and intuitive manner, ready for exploration. Applying this technique to the cases led the team to conclude that chronological age alone cannot be used as a risk factor for severity, but rather must always be accompanied by comorbidities and even habits (physiological age).

“We also observed that, under equivalent clinical conditions, women have a higher recovery rate than men and, among older people, it is those aged over 100 who recover best. And we found that there is significant variability in recovery rates between different states in Mexico and also depending on the clinical institution,” concluded Carlos Sáez.

Related Links:
Universitat Politècnica de València 

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Semi-Automatic Mobile Cushion System
CariChair
New
Disaster Preparedness Bed
Disaster Preparedness Bed

Print article

Channels

Critical Care

view channel
Image: The active substance TVEC led to a reduction in the size of the basal cell carcinoma in all study participants (Photo courtesy of 123RF)

Basal Cell Carcinoma Treatment Reduces Tumor Size, Improves Surgical Removal

Basal cell carcinomas, the most prevalent type of skin cancer, often appear in areas exposed to the sun, such as the face. Locally advanced tumors, in particular, present challenges for surgical treatment.... Read more

Surgical Techniques

view channel
Image: LumiSystem is the combination of two FDA approved products: LUMISIGHT (pegulicianine) and Lumicell Direct Visualization System (Photo courtesy of Lumicell)

Pioneering Technology Enables Real-Time Detection of Residual Breast Cancer During Lumpectomy

Breast cancer is the most frequently diagnosed cancer in women, with lumpectomies being the most common treatment approach. About 65% of women diagnosed with breast cancer undergo a lumpectomy, also referred... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.